| Mechanical and pharmacologic catheter-directed thrombolysis treatment of severe, symptomatic, bilateral deep vein thrombosis with congenital absence of the inferior vena cava. | |
| | |
MedLine Citation:
|
PMID: 21609802 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
We report the use of mechanical and pharmacologic catheter-directed thrombolysis in treating deep vein thrombosis with congenital absence of the inferior vena cava The patient presented with disabling bilateral lower extremity swelling and pain and was found to have extensive bilateral iliofemoral deep vein thromboses. Genetic testing revealed a factor V Leiden mutation. The patient underwent thrombolysis using a Possis (MEDRAD Inc, Warrendale, Pa) catheter and overnight infusion of tissue plasminogen activator. The patient tolerated the procedure well, with prompt return to daily activities. He remains free of symptoms at 3 years on oral anticoagulation, with a patent venous architecture. |
| | |
Authors:
|
Karan Garg; Neal Cayne; Glenn Jacobowitz |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: Journal of vascular surgery Volume: 53 ISSN: 1097-6809 ISO Abbreviation: J. Vasc. Surg. Publication Date: 2011 Jun |
Date Detail:
|
Created Date: 2011-05-25 Completed Date: 2011-08-15 Revised Date: 2012-10-03 |
Medline Journal Info:
|
Nlm Unique ID: 8407742 Medline TA: J Vasc Surg Country: United States |
Other Details:
|
Languages: eng Pagination: 1707-10 Citation Subset: IM |
Copyright Information:
|
Copyright © 2011 Society for Vascular Surgery. All rights reserved. |
Affiliation:
|
Department of Surgery, New York University Langone Medical Center, New York, NY 10016, USA. karan.garg@nyumc.org |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Anticoagulants / administration & dosage Catheterization, Peripheral Fibrinolytic Agents / administration & dosage Humans Male Thrombolytic Therapy* Tissue Plasminogen Activator / administration & dosage Vascular Malformations / complications* Vena Cava, Inferior / abnormalities* Venous Thrombosis / etiology, therapy* |
| Chemical | |
Reg. No./Substance:
|
0/Anticoagulants; 0/Fibrinolytic Agents; EC 3.4.21.68/Tissue Plasminogen Activator |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Rapid recurrence of cystic adventitial disease in femoral artery and an etiologic consideration for ...
Next Document: Masson's vegetant intravascular hemangioendothelioma in an external jugular vein aneurysm with recur...